Across TCGA pan-cancer cohorts, RNVU1-34 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RNVU1-34’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where RNVU1-34 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNVU1-34 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

BLCA, BRCA, and STAD are the cancer types where RNVU1-34 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNVU1-34 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.448	.017	6	view →
BRCA	Female	All	−0.201	.007	4	view →
STAD	Female	All	+0.641	.023	2	view →
COAD	Female	All	+0.132	.044	1	view →
LUAD	All	All	+0.113	.019	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RNVU1-34 RNA expression & survival · all RNVU1-34 data types